ESMO 2023 | Unmet needs in glioma treatment

Enrico Franceschi, MD, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy, outlines some of the unmet needs for patients with low-grade gliomas. Consideration of the timing of interventions, matching patients to their most suitable therapeutic strategies and interpreting who is likely to benefit from different treatments are among the barriers discussed. Anti-IDH agents may be beneficial for treating gliomas, but more analysis on who is eligible for these treatments is needed. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.